Skip to main content
An official website of the United States government

Chemopreventive Agent Development

Designs, develops, implements, and monitors research on interventions that may block, reverse, or delay the early stages of cancer. Investigates nutrients, micronutrients, natural products, pharmacologic agents, biomolecules, and vaccines from preclinical to early-phase I clinical studies. Helps investigators to bridge the gaps between biology and identifying potential targets, and between discovery of targets and agents and clinical testing in people.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

Major Programs

Staff List

Photo Name, Email, Phone Room Group(s)/Office
Asefa, Wosene
wosene.asefa@nih.gov
240-276-6422
5E504 Program Support Assistant | Chemopreventive Agent Development
Biswas, Kajal, Ph.D.
kajal.biswas2@nih.gov
240-276-5614
5E540 Program Officer | Chemopreventive Agent Development
Cholewa, Brian, Ph.D.
brian.cholewa@nih.gov
240-276-7545
5E446 Deputy Chief | Chemopreventive Agent Development
Clifford, John, Ph.D.
john.clifford@nih.gov
202-235-4482
5E430 Program Officer | Chemopreventive Agent Development
Gunasekharan, Vignesh, Ph.D.
vignesh.gunasekharan@nih.gov
240-276-5814
5E438 Program Officer | Chemopreventive Agent Development
Mohammed, Altaf, Ph.D.
altaf.mohammed@nih.gov
240-276-6082
5E542 Deputy Chief | Chemopreventive Agent Development
Nalli, Ancy, Ph.D., M.S.
ancy.nalli@nih.gov
202-276-5265
5E536 Program Officer | Chemopreventive Agent Development
Sei, Shizuko, M.D.
shizuko.sei@nih.gov
240-276-5005
5E452 Co-Chief | Chemopreventive Agent Development
Shoemaker, Robert, Ph.D.
robert.shoemaker@nih.gov
240-276-7077
5E454 Co-Chief | Chemopreventive Agent Development
Acting Chief | Nutritional Science
Vlad, Anda, M.D., Ph.D.
anda.vlad@nih.gov
240-276-6422
5E538 Program Officer | Chemopreventive Agent Development

Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Yaddanapudi, Kavitha

University Of Louisville
United States

A Stem Cell Based Exosomal Vaccine for the Prevention of Cancer 5R21CA277314-02
Yaghjyan, Lusine

University Of Florida
United States

Stromal contributions to breast carcinogenesis 5R01CA277817-03 Christos Patriotis, Ph.D., M.Sc.
Yang, Qing

University Of Texas Med Br Galveston
United States

The role of acute excitation of sensory neurons in the development of paclitaxel-induced peripheral neuropathy 5R01CA273001-02 Rachel Altshuler, Ph.D.
Yang, Wan

Columbia University Health Sciences
United States

UNCOVER: underlying novel causes of onset of very early cancer research 5R01CA257971-05 Nicholas Hodges, Ph.D.
Yeh, Jennifer M.

Boston Children'S Hospital
United States

Can risk-reducing medications improve breast cancer prevention in childhood and adolescent cancer survivors? Comparative modeling to inform care 5R01CA261874-04 Eileen Dimond, R.N., M.S.
Yendamuri, Saikrishna

Roswell Park Cancer Institute Corp
United States

Metformin for chemoprevention of lung cancer in obese subjects at high risk 5R01CA255515-05 Malgorzata Wojtowicz, M.D.
Yilmaz, Omer

Massachusetts Institute Of Technology
United States

PROSPECT - Stem cell models 3OT2CA297570-01S1 Asad Umar, D.V.M., Ph.D.
You, Ming

Methodist Hospital Research Institute
United States

Targeting phenethyl isothiocyanate to mitochondria in lung carcinogenesis 5R01CA280746-02 John Clifford, Ph.D.
Young, Steven L

Duke University
United States

Collaborative Center to Develop Improved Diagnostic and Therapeutic Approaches to Endometriosis 5P01HD106485-05 Goli Samimi, Ph.D., M.P.H.
Yu, Danxia

Vanderbilt University Medical Center
United States

Gut microbiota-related mechanisms that impact colorectal cancer risk after bariatric surgery 5R01CA275864-03 Edward Sauter, M.D., Ph.D.
Yu, Dihua

University Of Tx Md Anderson Can Ctr
United States

Exploring novel strategies for immunoprevention of estrogen receptor negative breast cancer 5R01CA270010-03 Marjorie Perloff, M.D.
Yu, Anthony Francis

Sloan-Kettering Inst Can Research
United States

Intensive Blood Pressure Control During Cardiotoxic Breast Cancer Treatment (PROTECT) Trial 5R37CA273923-03 Eileen Dimond, R.N., M.S.
Yuan, Ying

University Of Tx Md Anderson Can Ctr
United States

Coordinating and Data Management Center for Translational and Basic Science Research in Early Lesions 5U24CA274212-04 Christos Patriotis, Ph.D., M.Sc.
Zarrinpar, Amir

University Of California, San Diego
United States

Engineering Native E. coli to Detect, Report, and Treat Colorectal Cancer 5U01CA265719-05 Guillermo Marquez, Ph.D.
Zeng, Melody Yue

Weill Medical Coll Of Cornell Univ
United States

Dissecting the interplay between immunoglobulin G and the gut microbiome in cancer progression and metastasis 5R21CA270998-02 Young Kim, Ph.D.